期刊文献+

鲍氏不动杆菌的耐药性分析 被引量:1

The analysis of drug resistance of Acinetobacter sp
下载PDF
导出
摘要 目的汇总我院分离的鲍氏不动杆菌的分布及耐药性,为医院感染防控工作提供数据,为临床合理选择抗生素提供依据。方法对我院2013年1月—12月临床分离的153株鲍氏不动杆菌的耐药情况进行分析,应用英国先德全自动微生物分析仪进行菌种鉴定和药敏试验。结果鲍氏不动杆菌病情分布情况:ICU34.6%,内分泌科17.6%,神经外科17.0%,呼吸内科16.3%,神经内科7.8%;临床标本中以痰及分泌物标本为主。对鲍氏不动杆菌的耐药情况分析显示,我院的鲍氏不动杆菌耐药情况比较严重,亚胺硫霉素的耐药率为27.3%;泛耐药菌株检出率为12.4%。结论鲍氏不动杆菌的耐药情况十分严重且呈现多重耐药,医院应重视鲍氏不动杆菌耐药性的监测与控制,预防多重耐药鲍氏不动杆菌医院感染的发生。 Objective To summarize the distribution and drug resistance of the acinetobacter baumanniiand that isolated in our hospital,and to provide the data for the hospital infection and to provide evidence for rational useofanti biotics.Methods Analysis of drug resistance of 153 casesac inetobacter baumanniiand in our hospital from January to December in 2013.The British full automatic microorganism analyzer was to be used for the identification and drug sensitivity test.Results The distribution of the acinetobacter baumanniiand:ICU(34.6%);endocrinology department(17%);neurosurgery(16.3%);respiratory medicine(7.8%).sputum and secretion were the main type of the clinical specimens. The drug resistance analysis of acinetobacter baumanniiand showed that the drug resistance of acinetobacter baumanniiand was seriousin our hospital. The resistance rate of Imipenemwas 27.3%,the detection rate of Pan resistant strains was 12.4%. The hospital should pay attention to monitorand control the drug resistance of acinetobacter baumanniiand,to prevent the occurrence of multi drug resistant strains.Conclusion The drug resistance of Acinetobacter was very serious,and had multiple drug resistance. The hospital should pay attention to monitor and control the drug resistance of Acinetobacter,and to prevent the occurrence of multiple drug resistant.
机构地区 大庆市第四医院
出处 《基层医学论坛》 2016年第31期4345-4346,共2页 The Medical Forum
关键词 鲍氏不动杆菌 耐药性分析 医院感染 预防控制 Acinetobacter baumanniiand Drug resistance Hospital infection Prevention control
  • 相关文献

参考文献4

二级参考文献24

  • 1李苏利,李杨,华川.多重耐药鲍氏不动杆菌耐药现状与临床对策[J].中华医院感染学杂志,2005,15(12):1438-1440. 被引量:102
  • 2吴建曾,钟馥霞.139例鲍曼不动杆菌的院内感染及耐药性分析[J].广东医学院学报,2006,24(3):260-261. 被引量:2
  • 3Lepper PM, Grusa E, Reichl H, et al. Consumption of Imipenem Correlates with β-Lactam Resistance in Pseudomonas aeruginosa [J]. Antimicrob Agents Chemother, 2002, 46: 2920-2925.
  • 4Urban C, Segal-Maurer S, Rahal JJ. Considerations in control and treatment of nosocomial infection due to multidrug-resistant Acinetobacter baumannii [J]. Clin Infect Dis, 2003, 36 (10) : 1268-1274.
  • 5Perez F, Hujer AM, Hujer KM, et al. Global challenge of multi- drug- resistant Acinetobacter baumannii [ J ]. Antimicrob Agents Chemother, 2007, 51 (10) : 3471 - 3484.
  • 6National Nosocomial Infections Surveillance System. National Noso- comial Infections Surveillance (NNIS) System Report, data summa-ry from January 1992 through June 2004, issued October 2004[ J]. Am J Infect Control, 2004, 32(8) : 470 -485.
  • 7Karageorgopoulous DE, Falagas ME. Current control and treatment of muhidrug-resistant Acinetobacter baumannii infections [ J ]. Lan- cet Infect Dis, 2008, 8(12) : 751 -762.
  • 8Peleg AY, Seifert H, Paterson DL. Acinetobacter bauman- nii: emergence of a successful pathogen[J]. Clin Microbiol Rev, 2008, 21:538-582.
  • 9Falagas ME, Koletsi PK, Bliziotis IA. The diversity of defi- nitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aerugi- nosa[ J]. J Med Microbiol, 2006, 55 : 1619-1629.
  • 10Paterson DL, Doi Y. A step closer to extreme drug resist- ance (XDR) in gram-negative bacill[ J]. Clin Infect Dis, 2007, 45 : 1179 -1181.

共引文献105

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部